Company / Operating Cash Flow per Share
Actinium Pharmaceuticals, Inc. Operating Cash Flow per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.79
FY2025
5-year range
-$1.71 / $0.34
FY2021-FY2025
Trend
+54.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 6 years, ranging from $-1.71 in FY2024 to $0.34 in FY2023.
Based on SEC 10-K filings.
-0.79 in FY2025.
Declined from $0.34 to $-0.79 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 54.0% year-over-year.
- Peak operating cash flow per share was recorded in FY2023.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.79 | +54.0% |
| FY2024 | -$1.71 | -608.8% |
| FY2023 | $0.34 | +135.7% |
| FY2022 | -$0.94 | +23.6% |
| FY2021 | -$1.23 | -2557.2% |
| FY2011 | -$0.05 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026